Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Ionis Pharmaceuticals
IONS
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$42.76
0
0.00%
Pre-Market: Sep 20, 4:04 PM EDT
15 minutes delayed
Get Report
Comment
Ionis Pharmaceuticals (IONS) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Ionis Pharmaceuticals (NASDAQ:IONS) Stock
Ionis Pharmaceuticals Stock (NASDAQ: IONS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, September 10, 2024
Rubrik Reports Q2 Results, Joins Ionis Pharmaceuticals, Hewlett Packard Enterprise And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Avi Kapoor
Ionis Pharmaceuticals shares are trading lowe...
Benzinga Newsdesk
Why Oracle Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Reported Earlier, Ionis Prices $500.3M Public...
Benzinga Newsdesk
Monday, September 09, 2024
Ionis Pharmaceuticals shares are trading lowe...
Benzinga Newsdesk
Ionis Pharmaceuticals Announces $500M Public ...
Benzinga Newsdesk
Monday, August 26, 2024
What 14 Analyst Ratings Have To Say About Ionis Pharmaceuticals
Benzinga Insights
JP Morgan Maintains Neutral on Ionis Pharmace...
Benzinga Newsdesk
Friday, August 02, 2024
Guggenheim Maintains Buy on Ionis Pharmaceuti...
Benzinga Newsdesk
Goldman Sachs Maintains Sell on Ionis Pharmac...
Benzinga Newsdesk
Barclays Maintains Equal-Weight on Ionis Phar...
Benzinga Newsdesk
12 Analysts Have This To Say About Ionis Pharmaceuticals
Benzinga Insights
Needham Reiterates Buy on Ionis Pharmaceutica...
Benzinga Newsdesk
BMO Capital Downgrades Ionis Pharmaceuticals ...
Benzinga Newsdesk
Thursday, August 01, 2024
Ionis Pharmaceuticals Q2 2024 Adj. EPS $(0.24...
Benzinga Newsdesk
Wednesday, July 31, 2024
Alcyone Therapeutics Announces Continued Enro...
Benzinga Newsdesk
Wednesday, July 24, 2024
Leerink Partners Upgrades Ionis Pharmaceutica...
Benzinga Newsdesk
Tuesday, July 23, 2024
TD Cowen Maintains Buy on Ionis Pharmaceutica...
Benzinga Newsdesk
B of A Securities Maintains Buy on Ionis Phar...
Benzinga Newsdesk
Monday, July 22, 2024
Ionis Pharmaceuticals shares are trading high...
Benzinga Newsdesk
Needham Reiterates Buy on Ionis Pharmaceutica...
Benzinga Newsdesk
Ionis' Rare Development Disorder Drug Candidate 'Could Be Differentiated' From Peer Ultragenyx: Analyst
Vandana Singh
Ionis Pharmaceuticals Announces Phase 1/2 Res...
Benzinga Newsdesk
Thursday, July 18, 2024
Ionis Pharmaceuticals Has Completed Enrollmen...
Benzinga Newsdesk
Tuesday, July 16, 2024
The Latest Analyst Ratings For Ionis Pharmaceuticals
Benzinga Insights
B of A Securities Maintains Buy on Ionis Phar...
Benzinga Newsdesk
Ionis Pharmaceuticals shares are trading high...
Benzinga Newsdesk
Jefferies Upgrades Ionis Pharmaceuticals to B...
Benzinga Newsdesk
Thursday, June 27, 2024
Assessing Ionis Pharmaceuticals: Insights From 6 Financial Analysts
Benzinga Insights
Stifel Maintains Hold on Ionis Pharmaceutical...
Benzinga Newsdesk
Tuesday, June 25, 2024
Ionis Pharmaceutics shares are trading higher...
Benzinga Newsdesk
FDA Has Accepted For Priority Review Ionis Ph...
Benzinga Newsdesk
Monday, June 24, 2024
RXO, Alnylam Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Avi Kapoor
Tuesday, June 18, 2024
Otsuka Pharmaceutical Obtains Exclusive Right...
Benzinga Newsdesk
Friday, June 14, 2024
Bernstein Upgrades Ionis Pharmaceuticals to M...
Benzinga Newsdesk
Monday, June 03, 2024
Deep Dive Into Ionis Pharmaceuticals Stock: Analyst Perspectives (6 Ratings)
Benzinga Insights
Needham Reiterates Buy on Ionis Pharmaceutica...
Benzinga Newsdesk
Friday, May 31, 2024
Ionis Pharmaceuticals Reveals Late-Stage Donidalorsen Data, Analyst Says Results Show Competitive Hereditary Angioedema Profile
Vandana Singh
Europe Approves Biogen's Tofersen For Adult Patients With Rare Type Of Neurodegenerative Disorder
Vandana Singh
Ionis Discloses Positive Results From OASIS-H...
Benzinga Newsdesk
Thursday, May 23, 2024
Ionis Pharmaceuticals Will Present New Subgro...
Benzinga Newsdesk
Friday, May 17, 2024
Ionis, Biogen Down on Ending Development of ALS Drug
Zacks
Thursday, May 16, 2024
Tale Of Two Ionis-Partnered Neurology-Focused Early Stage Assets-Biogen Discontinues One, Decides Not To Exercise Licensing Option For Another
Vandana Singh
Shares of Biogen and Ionis Pharmaceuticals ar...
Benzinga Newsdesk
Ionis And Biogen Say Development Of BIIB105 W...
Benzinga Newsdesk
Ionis Pharmaceuticals Announced Topline Data ...
Benzinga Newsdesk
Wednesday, May 08, 2024
The Analyst Landscape: 8 Takes On Ionis Pharmaceuticals
Benzinga Insights
Wells Fargo Maintains Overweight on Ionis Pha...
Benzinga Newsdesk
Needham Reiterates Buy on Ionis Pharmaceutica...
Benzinga Newsdesk
Tuesday, May 07, 2024
Ionis Pharmaceuticals Reports Q1 Adjusted Net...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch